Skip to main content
. 2024 Mar 7;109(8):2401–2419. doi: 10.3324/haematol.2022.282363

Table 3.

Randomized controlled trials comparing health-related quality of life after chimeric antigen receptor T-cell anti-CD19 therapy or standard of care in adult patients.

graphic file with name 1092401.tab3.jpg